Cargando…

Multicomponent Vaccines against Group A Streptococcus Can Effectively Target Broad Disease Presentations

Group A Streptococcus (GAS) is an important global human pathogen, with a wide range of disease presentations, from mild mucosal infections like pharyngitis to invasive diseases such as toxic shock syndrome. The effect on health and mortality from GAS infections is substantial worldwide, particularl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaw, Helen A., Ozanne, James, Burns, Keira, Mawas, Fatme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473114/ https://www.ncbi.nlm.nih.gov/pubmed/34579262 http://dx.doi.org/10.3390/vaccines9091025

Ejemplares similares

Progress towards a glycoconjugate vaccine against Group A Streptococcus
por: Burns, Keira, et al.
Publicado: (2023)

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
por: Palmieri, Elena, et al.
Publicado: (2022)

Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model
por: Shaw, Helen Alexandra, et al.
Publicado: (2023)

A Multicomponent Vaccine Provides Immunity against Local and Systemic Infections by Group A Streptococcus across Serotypes
por: Bi, Shuai, et al.
Publicado: (2019)

Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG
por: Reglinski, Mark, et al.
Publicado: (2016)

A Vaccine Against Group B Streptococcus: Recent Advances
por: Carreras-Abad, Clara, et al.
Publicado: (2020)

Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection
por: Masomian, Malihe, et al.
Publicado: (2020)

Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus
por: Di Benedetto, Roberta, et al.
Publicado: (2020)

A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge
por: Chiu, Fang-Feng, et al.
Publicado: (2023)

Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice
por: Shao, Meili, et al.
Publicado: (2010)

Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus
por: Tsoi, Shu Ki, et al.
Publicado: (2015)

Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan
por: Sorano, Sumire, et al.
Publicado: (2023)

Rational development of multicomponent mRNA vaccine candidates against mpox
por: Zhang, Rong-Rong, et al.
Publicado: (2023)

Control of Streptococcal Infections: Is a Common Vaccine Target Achievable Against Streptococcus agalactiae and Streptococcus pneumoniae
por: Bedeley, Edmund, et al.
Publicado: (2021)

Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2019)

Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2022)

Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus
por: Chen, Shuxiong, et al.
Publicado: (2023)

Update on the development of Group A Streptococcus vaccines
por: Ajay Castro, Sowmya, et al.
Publicado: (2023)

Protein Array Profiling of Tic Patient Sera Reveals a Broad Range and Enhanced Immune Response against Group A Streptococcus Antigens
por: Bombaci, Mauro, et al.
Publicado: (2009)

Vaccines Directed Against Microorganisms or Their Products Present During Biofilm Lifestyle: Can We Make a Translation as a Broad Biological Model to Tuberculosis?
por: Flores-Valdez, Mario A.
Publicado: (2016)

Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A Streptococcus
por: Zhao, Lili, et al.
Publicado: (2020)

Development and evaluation of a multi-epitope subunit vaccine against group B Streptococcus infection
por: Zhang, Yumin, et al.
Publicado: (2022)

Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A Streptococcus
por: Kiong, Jolynn, et al.
Publicado: (2022)

A subunit vaccine against pneumonia: targeting Streptococcus pneumoniae and Klebsiella pneumoniae
por: Rafi, Md. Oliullah, et al.
Publicado: (2023)

A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice
por: Alves, Joana, et al.
Publicado: (2015)

Group B streptococcus vaccines: one step further
por: Berner, Reinhard
Publicado: (2021)

Presentation and outcomes of orbital cellulitis caused by Group F Streptococcus
por: Mehta, Viraj J., et al.
Publicado: (2021)

Polyacrylate–Peptide Antigen Conjugate as a Single-Dose Oral Vaccine against Group A Streptococcus
por: Faruck, Mohammad Omer, et al.
Publicado: (2020)

Importance of Functional Assessment of Immunity against Group B Streptococcus
por: Lee, Hyunju
Publicado: (2018)

Epitope-targeting platform for broadly protective influenza vaccines
por: Zeigler, David F., et al.
Publicado: (2021)

A multivalent T-antigen-based vaccine for Group A Streptococcus
por: Loh, Jacelyn M. S., et al.
Publicado: (2021)

Renal Interstitial Invasion by Group A Streptococcus: A Rare Presentation
por: Lomanta, Francis, et al.
Publicado: (2022)

A broadly protective vaccine against cutaneous human papillomaviruses
por: Mariz, Filipe Colaco, et al.
Publicado: (2022)

Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions
por: Seale, Anna C., et al.
Publicado: (2019)

Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries
por: Kobayashi, Miwako, et al.
Publicado: (2016)

A broad spectrum of posterior reversible encephalopathy syndrome - a case series with clinical and paraclinical characterisation, and histopathological findings
por: Ismail, Fatme Seval, et al.
Publicado: (2021)

Group A Streptococcus
por: Hand, Robert M., et al.
Publicado: (2020)

Group A Streptococcus
por: Snelling, Thomas L, et al.
Publicado: (2013)

Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis
por: Gasparini, Roberto, et al.
Publicado: (2016)

Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis
por: de Mendonça, Ludmila Zanandreis, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m8vcsed1k7kssmgo0ometese8s